End stage liver disease

Part 1 book "Clinical pharmacy and therapeutics" includes content: Clinical pharmacy process, practical pharmacokinetics, drug interactions, adverse drug reactions, laboratory data, parenteral nutrition, liver disease, cute kidney injury, chronic kidney disease and end-stage renal disease, coronary heart disease.

493p zizaybay1101 30-04-2024 3 2   Download

In cirrhotic patients, variceal bleeding remains a major cause of death. After a variceal bleeding episode, mortality and rebleeding rates spike for the first 6 weeks before levelling off. We aimed to evaluate the performance of AIMS65 score in comparison with Child-Turcotte-Pugh (CTP) score and model for end-stage liver disease (MELD) score in predicting 6-week mortality and rebleeding in cirrhotic patients with variceal bleeding.

5p vikissinger 21-12-2023 3 1   Download

End stage liver disease (ESLD) is associated with significant thrombotic complications. In this study, we attempted to determine if patients with ESLD, due to oncologic or autoimmune diseases, are susceptible to thrombosis to a greater extent than patients with ESLD due to other causes.

7p viisaacnewton 25-04-2022 18 1   Download

Perioperative hyperglycemia is associated with poor outcomes yet evidence to guide intraoperative goals and treatment modalities during non-cardiac surgery are lacking. End-stage liver disease is associated with altered glucose homeostasis; patients undergoing liver transplantation display huge fluctuations in blood glucose (BG) and represent a population of great interest.

11p vizhangzhidong 29-12-2021 14 0   Download

Mini-fluid challenge is a well tested and effective tool to predict fluid responsiveness under various clinical conditions. However, mini-fluid challenge has never been tested in patients with end-stage liver disease. This study investigated whether infusion of 150 ml albumin 5% can predict fluid responsiveness in cirrhotic patients following liver transplant.

6p vizhangzhidong 29-12-2021 10 0   Download

Hepatic hydrothorax is a major pulmonary complication of liver disease occurring in up to 5-10% of patients with cirrhosis. While pneumothorax ex-vacuo is a known phenomenon in malignant effusions, to our knowledge, it has never been described in association with hepatic hydrothoraces.

6p vianthony2711 16-04-2021 8 1   Download

The incidence of non-alcoholic steatohepatitis (NASH) is increasing worldwide and a poorly defined subset of patients develops end-stage liver disease and hepatocellular carcinoma (HCC). Differences in the biological behaviour, tumour characteristics, associated risk factors, treatment outcomes and overall survival of patients with NASH-HCC remain poorly defined.

9p vialabama2711 21-09-2020 13 2   Download

Viral infections account for significant proportion of CLD. Hepatitis C virus is the major cause of non-A, non-B hepatitis worldwide. HCV can lead to chronic liver disease causing cirrhosis, hepatocellular carcinoma and end stage liver disease among 5-20% of infected persons. In India about 20 million people are known to have HCV infection and a quarter of them are expected to develop chronic liver disease in the next 10-15 years. 1) To determine prevalence of Hepatitis C virus infection in chronic liver disease patients. 2) To identify the risk factor for HCV infection.

9p nguathienthan5 04-06-2020 17 1   Download

Transplantation of hepatitis C virus (HCV)-positive organs has undergone a paradigm shift because of the advent of direct-acting antivirals. We present the case of a 57-year-old man successfully treated initially with pegylated interferon and ribavirin after HCV recurrence postliver transplantation. He subsequently developed end-stage renal disease and received a genotype 1a HCV-positive kidney transplant. A 12-week course of ledipasvir/sofosbuvir and low-dose ribavirin was initiated and sustained virologic response was achieved.

3p covid19 11-05-2020 23 0   Download

Forty years ago, just prior to the discovery of the hepatitis B surface antigen, the concept that chronic liver disease could be a sequel to infection by any agent of acute viral hepatitis was controversial and hotly debated. With the development of specific and sensitive serologic and virologic markers of infection by the bloodborne and enterically transmitted hepatitis viruses, the linkage of the former agents with chronic hepatitis, cirrhosis, end-stage liver disease, and hepatocellular carcinoma was established beyond doubt....

350p crazy_sms 07-05-2012 76 16   Download

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học quốc tế cung cấp cho các bạn kiến thức về ngành y đề tài: Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients...

10p coxanh_6 30-10-2011 53 2   Download

The Model for End-Stage Liver Disease, or MELD, is a scoring system for assessing the severity of chronic liver disease. It was initially developed to predict death within three months of surgery in patients who had undergone a transjugular intrahepatic portosystemic shunt (TIPS) procedure, and was subsequently found to be useful in determining prognosis and prioritizing for receipt of a liver transplant. This score is now used by the United Network for Organ Sharing (UNOS) and Eurotransplant for prioritizing allocation of liver transplants instead of the older Child-Pugh score. ...

3p truongthiuyen1 08-06-2011 86 4   Download